Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.
ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases
Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).
Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.
Lomond Therapeutics creates pharmacological platforms that target escape mutations.
Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.
Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.
Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.
Congruence Therapeutics operates as a biotechnology company.
Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.
Harvest Integrated Research Organization (HiRO) is a globally oriented, innovative clinical research organization (CRO).
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Cyrus Biotechnology is a developer of Rosetta software platform that solves drug discovery problems.
Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.
Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.
Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.
Leal Therapeutics develops novel therapeutics for patients.
OrbiMed has invested in 289 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OrbiMed's top investment sectors include Biotechnology, Medical, Health Care, Therapeutics, Biopharma. The firm invests across 14 different industry categories.
Among tracked funding rounds, Cullinan Therapeutics received $280.0M in a Post-IPO Equity round. OrbiMed's total known invested capital is $23.6B.
OrbiMed's average investment size is $104.0M across its portfolio of 289 companies.
Recent OrbiMed portfolio additions include Cullinan Therapeutics, Terremoto Biosciences, ImageneBio, Sionna Therapeutics, Apollomics. These companies were founded in 2020 or later.